Institute of Cardiology, Warsaw, Poland Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Warsaw Poland (1991)

Organization Overview

First Clinical Trial
2004
NCT00371098
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

1st Dept of Coronary Artery Disease, Institute of Cardiology, Warsaw, Poland | Coronary and Structural Heart Diseases Department, Institute of Cardiology, Warsaw, Poland | Institute of Cardiology, Warsaw, Poland

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Atrial Fibrillation (Phase 4)

Coronary Artery Disease (Phase 3)

Coronary Disease (Phase 3)

Heart Failure (Phase 4)

Influenza, Human (Phase 3)

Myocardial Ischemia (Phase 3)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 11